31 December 2019
| Ordinary Shares | Average Exercise Price | Expiration | |
| Issued & Outstanding Shares | 561,995,785 | ||
| Shares not in Public Hands | 472,528,123 | ||
| Free Float | 89,467,662 | ||
| Restricted Share Options (1) | 31,900,000 | £0.030 | expire 2026/27 |
| Potential Secured Financing Conversion (2) | 221,118,369 | ||
| Total Fully Diluted Shares (3) | 815,014,154 | ||
-
- Restricted Share Options in issue do not have voting rights and therefore, are not included in voting shares on issue calculations
- Potential Secured Financing Conversion As of 31 December 2019 the Company had £8,055,918 outstanding under the 2017 Secured Financing Facility, with a further three tranches of £1 million to be drawn down on 30 June 2020, 31 December 2020 and 30 June 2021. This 2017 Secured Financing Facility no longer incurs interest and the Lenders have an option to convert into New Ordinary Shares at a price of 5 pence per Ordinary Share, and so could, if fully drawn, be converted into 221,118,369 Ordinary Shares
- Total Fully Diluted Shares are calculated as Issued Shares plus Total Restricted Share Options plus the Potential Secured Financing Conversion Shares
In addition, on 17 September 2015, each of the Company’s existing Ordinary shares were subdivided into one Ordinary Share of 1 pence and one Deferred Share of 4.7142865 pence. Consequently, other than the Ordinary Shares referenced in the above table, there are in issue 121,989,500 Deferred Shares. The rights of both the Ordinary and the Deferred Shares are as set out in the Articles of Association as amended 14 September 2015 found on the Corporate Association documents page of this website